These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 15591221

  • 1. Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery.
    Sakamoto K, Murata T, Chuma H, Hori M, Ozaki H.
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):327-33. PubMed ID: 15591221
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional down-regulation of thromboxane A(2) receptor expression via activation of MAPK ERK1/2, p38/NF-kappaB pathways.
    Zhang W, Zhang Y, Edvinsson L, Xu CB.
    J Vasc Res; 2009 Feb; 46(2):162-74. PubMed ID: 18769070
    [Abstract] [Full Text] [Related]

  • 3. Chronic treatment with PDGF-BB and endothelin-1 synergistically induces vascular hyperplasia and loss of contractility in organ-cultured rat tail artery.
    Kida T, Chuma H, Murata T, Yamawaki H, Matsumoto S, Hori M, Ozaki H.
    Atherosclerosis; 2011 Feb; 214(2):288-94. PubMed ID: 21129745
    [Abstract] [Full Text] [Related]

  • 4. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
    Francis DJ, Parish CR, McGarry M, Santiago FS, Lowe HC, Brown KJ, Bingley JA, Hayward IP, Cowden WB, Campbell JH, Campbell GR, Chesterman CN, Khachigian LM.
    Circ Res; 2003 May 02; 92(8):e70-7. PubMed ID: 12690039
    [Abstract] [Full Text] [Related]

  • 5. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
    Cirillo P, Calì G, Golino P, Calabrò P, Forte L, De Rosa S, Pacileo M, Ragni M, Scopacasa F, Nitsch L, Chiariello M.
    Circulation; 2004 Jun 15; 109(23):2911-6. PubMed ID: 15173027
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
    Gennaro G, Ménard C, Michaud SE, Deblois D, Rivard A.
    Circulation; 2004 Nov 23; 110(21):3367-71. PubMed ID: 15520324
    [Abstract] [Full Text] [Related]

  • 7. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
    Uruno A, Sugawara A, Kudo M, Satoh F, Saito A, Ito S.
    Hypertens Res; 2008 Nov 23; 31(11):2085-96. PubMed ID: 19098381
    [Abstract] [Full Text] [Related]

  • 8. TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production.
    Lee GL, Chang YW, Wu JY, Wu ML, Wu KK, Yet SF, Kuo CC.
    Arterioscler Thromb Vasc Biol; 2012 Nov 23; 32(11):2751-60. PubMed ID: 22995520
    [Abstract] [Full Text] [Related]

  • 9. Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension.
    Carlin CM, Celnik DF, Pak O, Wadsworth R, Peacock AJ, Welsh DJ.
    Am J Respir Cell Mol Biol; 2012 Aug 23; 47(2):140-8. PubMed ID: 22383583
    [Abstract] [Full Text] [Related]

  • 10. Effects of statin treatment and withdrawal on angiotensin II-induced phosphorylation of p38 MAPK and ERK1/2 in cultured vascular smooth muscle cells.
    Tristano AG, Castejon AM, Castro A, Cubeddu LX.
    Biochem Biophys Res Commun; 2007 Feb 02; 353(1):11-7. PubMed ID: 17161379
    [Abstract] [Full Text] [Related]

  • 11. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
    Li B, Yang L, Shen J, Wang C, Jiang Z.
    Anesth Analg; 2007 Oct 02; 105(4):1034-41, table of contents. PubMed ID: 17898384
    [Abstract] [Full Text] [Related]

  • 12. G-protein-mediated signaling in cholesterol-enriched arterial smooth muscle cells. 1. Reduced membrane-associated G-protein content due to diminished isoprenylation of G-gamma subunits and p21ras.
    Pomerantz KB, Lander HM, Summers B, Robishaw JD, Balcueva E, Hajjar DP.
    Biochemistry; 1997 Aug 05; 36(31):9523-31. PubMed ID: 9235998
    [Abstract] [Full Text] [Related]

  • 13. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
    Nagata T, Kai H, Shibata R, Koga M, Yoshimura A, Imaizumi T.
    Arterioscler Thromb Vasc Biol; 2003 Apr 01; 23(4):588-93. PubMed ID: 12615664
    [Abstract] [Full Text] [Related]

  • 14. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells.
    Gao P, Wu X, Shui H, Jia R.
    J Nephrol; 2013 Apr 01; 26(2):289-96. PubMed ID: 22641573
    [Abstract] [Full Text] [Related]

  • 15. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
    Tanikawa T, Okada Y, Tanikawa R, Tanaka Y.
    J Vasc Res; 2009 Apr 01; 46(6):572-80. PubMed ID: 19571577
    [Abstract] [Full Text] [Related]

  • 16. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling.
    Sedding DG, Tröbs M, Reich F, Walker G, Fink L, Haberbosch W, Rau W, Tillmanns H, Preissner KT, Bohle RM, Langheinrich AC.
    Circ Res; 2009 May 22; 104(10):1192-200. PubMed ID: 19372464
    [Abstract] [Full Text] [Related]

  • 17. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury.
    Xu Z, Wang BR, Wang X, Kuang F, Duan XL, Jiao XY, Ju G.
    Life Sci; 2006 Oct 12; 79(20):1895-905. PubMed ID: 16978658
    [Abstract] [Full Text] [Related]

  • 18. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
    Liu W, Liang Q, Balzar S, Wenzel S, Gorska M, Alam R.
    J Allergy Clin Immunol; 2008 Apr 12; 121(4):893-902.e2. PubMed ID: 18395552
    [Abstract] [Full Text] [Related]

  • 19. C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2.
    Walcher D, Babiak C, Poletek P, Rosenkranz S, Bach H, Betz S, Durst R, Grüb M, Hombach V, Strong J, Marx N.
    Circ Res; 2006 Nov 24; 99(11):1181-7. PubMed ID: 17068290
    [Abstract] [Full Text] [Related]

  • 20. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K, Adachi S, Maejima Y, Tamamori-Adachi M, Suzuki J, Kitajima S, Ito H, Isobe M.
    Life Sci; 2006 Aug 29; 79(14):1380-90. PubMed ID: 16712874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.